Anthea Pharma

Overview

Anthea Pharma Pvt. Ltd. describes itself as a young, R&D-focused injectables firm aiming to operate as a global CDMO for injectable manufacturing. Based in Hyderabad, India, and established in 2019, the company is backed by the Yashoda Group.

Services

• Formulation and scale-up development for injectable drug products
• Lyophilization process optimization, scale-up, and technology transfer
• Method development and phase-appropriate qualification, supported by an in-house analytical development department
• Aseptic fill and finish, including vial filling and lyophilization
• Terminal sterilization for syringe and vial formats, with cycle development and validation
• Prefilled syringe and vial fill-finish capabilities
• Dispensing and compounding, using stainless steel vessels or disposable formulation technology
• On-site chemical and microbiological quality laboratories

Products and Capabilities

The company lists liquid vials, lyophilized vials, prefilled syringes, ampoules, bags, and drops as current products, with efforts underway for peptides, long-acting injectables, suspensions, and hormonal products. Pens and cartridges are planned additions.

Manufacturing Scale

The company reports five manufacturing lines and states an infrastructure designed to develop 30 to 40 molecules per year. Its injectable plant is described as in process of being set up.

Quality and Operations

Formulation technicians are described as manufacturing in accordance with cGMP and global standards. Quality systems include a Manufacturing Execution System, Quality Management System, Laboratory Management System, and SAP.